Tagged with investment,

China Competition is heating up among Asian stock exchanges hoping to lure the hottest prospects in Chinese biotech to list there. The newest competitor, Shanghai’s STAR Board, has already attracted over 100 companies, some of which have reconsidered listing on the Hong Kong Exchange, wary of the HKEX’s lukewarm performance.  …

Spain Many of the world’s mega-rich are increasingly active philanthropists in the healthcare arena and Spain is no exception with Galician billionaire Amancio Ortega Gaona, the 82-year-old owner of clothing empire Inditex Fashion Group, which comprises iconic brands such as Zara and Massimo Dutti, embarking upon something of a spending spree…

Thailand Nares Damrongchai and Sirasak Teparkum from the Thailand Center of Excellence for Life Sciences (TCELS) lay out current challenges in the Thai healthcare and life sciences industry, their mains axes of research as well as how TCELS is helping the development of Thai startups and expanding international collaboration.   Thailand…

Taiwan Stéphane Péden, general manager of the Chamber of Commerce & Industry France Taiwan (CCIFT), describes how the Chamber facilitates business relations between France and Taiwan, the challenges faced by French companies setting up operations in Taiwan, and the numerous opportunities that Taiwan has to offer the French business community.  …

Puerto Rico Manuel Laboy Rivera, Secretary of the Department of Economic Development and Commerce (DEDC) and Executive Director of the Puerto Rico Industrial Development Company (PRIDCO) is discussing Puerto Rico’s integrated economic development plan, which aims to retain and expand current investment by the industry, while also attracting new companies to the…

Thailand Thailand boasts one of the most attractive business and investment environments in the ASEAN region, and pharmaceutical companies implanted in the country benefit from a highly-skilled workforce and enabling infrastructure. Despite some areas in which the country can improve, as well as a degree of political uncertainty, experts still have…

Japan Japan’s Opportunity to Establish a Blueprint for the World: Janssen Japan’s Chris Hourigan makes the case for increased investment in, and access to, innovative medicines as a key solution to countering the costs associated with an ageing population.   Earlier this year, Emperor Naruhito ascended the Chrysanthemum Throne, and Japan…

Morocco Spanish plasma specialist Grifols is making a move to invest in Africa, and was recently selected as the supplier for Soludia Maghreb’s new plant in Morocco. The CEOs of both companies see the deal as the first step in a long-term collaboration.    Grifols, founded in Barcelona in 1940, is…

Thailand Sukanya Uerchuchai, executive director of the Franco-Thai Chamber of Commerce, introduces one of the most dynamic European Chambers in Thailand, highlights the trade between Thailand and France, and explains the investment opportunities that Thailand offers for French companies.   Thailand is the second largest economic partner of France in Southeast…

Taiwan Yu-Ih Hou, mayor of New Taipei City, introduces the city and highlights its key competitive advantages and strategic direction of growth as Taiwan’s top economic and cultural destination.   Over one-fourth of Taiwan’s biomedical industry is based in the greater Taipei community – most of which are small companies carrying…

Sweden The American Chamber of Commerce in Sweden promotes trade and investment between the USA and Sweden. Peter Dahlen, AmCham Sweden’s managing director, outlines the significance of Swedish American ties, both macroeconomically and from a healthcare investment standpoint. This is in addition to the success of American companies in the country…

USA Christopher P. Molineaux of Life Sciences Pennsylvania outlines the Keystone State’s rich lineage of pharmaceutical innovation, how the association is building inter-state and international connections, and why Philadelphia is justified in branding itself as the ‘Cellicon Valley’.   We are at the epicentre of cell and gene therapy, what we…